Cargando…
Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients
Glioblastoma is a highly aggressive tumour of the central nervous system, characterised by poor prognosis irrespective of the applied treatment. The aim of our study was to analyse whether the molecular markers of glioblastoma (i.e. TP53 and IDH1 mutations, CDKN2A deletion, EGFR amplification, chrom...
Autores principales: | Bieńkowski, Michał, Piaskowski, Sylwester, Stoczyńska-Fidelus, Ewelina, Szybka, Małgorzata, Banaszczyk, Mateusz, Witusik-Perkowska, Monika, Jesień-Lewandowicz, Emilia, Jaskólski, Dariusz J., Radomiak-Załuska, Anna, Jesionek-Kupnicka, Dorota, Sikorska, Beata, Papierz, Wielisław, Rieske, Piotr, Liberski, Paweł P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675194/ https://www.ncbi.nlm.nih.gov/pubmed/23762372 http://dx.doi.org/10.1371/journal.pone.0065444 |
Ejemplares similares
-
Limited importance of the dominant-negative effect of TP53 missense mutations
por: Stoczynska-Fidelus, Ewelina, et al.
Publicado: (2011) -
Astrocytoma-associated antigens - IL13Rα2, Fra-1, and EphA2 as potential markers to monitor the status of tumour-derived cell cultures in vitro
por: Witusik-Perkowska, Monika, et al.
Publicado: (2014) -
Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies
por: Witusik-Perkowska, Monika, et al.
Publicado: (2010) -
Glioma cells showing IDH1 mutation cannot be propagated in standard cell culture conditions
por: Piaskowski, S, et al.
Publicado: (2011) -
Glioblastoma-derived cells in vitro unveil the
spectrum of drug resistance capability – comparative study of tumour
chemosensitivity in different culture systems
por: Witusik-Perkowska, Monika, et al.
Publicado: (2017)